Hospital begs for help identifying woman who has been in their care for past 100 days
On April 12 around 4:45am, a woman believed to be in her late-fifties was sitting at a Harlem bus stop when a bystander dialed 911.
It is unclear why an ambulance was called, but she was taken to Mount Sinai in Morningside Heights - where she has remained ever since.
Employees have described the mysterious patient, who may go by the name Pam, as shy. In a photo shared by the hospital, she was seen covering her face with a towel.
But these surface-level details are all officials have gathered about Pam during her three months at the hospital, and now hospital workers are trying to fill in the gaps.
The hospital is asking anyone with information on who she might be to come forward, NBC reported.
Pam is 5'8" tall and weighs 170 pounds. Hospital workers believe she was often in the Harlem area and generally wore black and covered her face. She speaks English and has greying hair.
The Daily Mail has reached out to Mount Sinai for comment.
Anyone with information regarding Pam's identity should contact the hospital's associate director of social work Kelly LaTerra at 646-901-9309.
Last month, a California man was found unconscious and was rushed to St. Mary Medical Center in Long Beach.
He was believed to be in his mid-forties, but just as in Pam's case, little else was known about the patient.
A chilling photo released by Dignity Health showed the man lying in a hospital bed, hooked up to a ventilator.
In October 2024, another California hospital took a similar approach to Mount Sinai in hopes of identifying a seriously ill patient.
Staff at the Riverside Community Hospital had done everything they could think of, but could not determine the name of a man who came through the facility's doors a month earlier.
They refused to say what was wrong with him or why he was attached to a ventilator, but released a photograph in the hopes that someone can put a name to the face.
Identifying John or Jane Doe patients is no easy task, as doctors and other hospital staff members must work to find out who they are without violating their rights.
The New York Department of Health has protocols in place specifically for missing children, college students and vulnerable adults.
These standards were set in 2018 after 'several instances of a missing adult with Alzheimer's disease who was admitted to a hospital as an unidentified patient and police and family members were unable to locate the individual.'
However, the process is not as cut and dry when it is the hospital asking for the public's help instead of the other way around.
While hospitals have been known to share images of unknown patients when all else fails, they are not allowed to reveal much about their circumstances.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Guardian
an hour ago
- The Guardian
Sales of Novo Nordisk's diabetes drugs including Ozempic slow sharply
Sales of Novo Nordisk's injectable diabetes drugs including Ozempic have slowed sharply amid fierce competition and the threat of US tariffs, prompting it to cut costs and sharpen its commercial focus. The Danish drugmaker, whose booming sales of GLP-1 diabetes and obesity drugs in recent years had turned it into Europe's most valuable company, has lost nearly $100bn (£75bn) in market value since cutting its full-year sales forecast last week, when its share price slid 30% in its worst week in more than two decades. It fell a further 3% on Wednesday. On Wednesday, Novo Nordisk said sales of medications such as Ozempic – which mimic the GLP-1 gut hormone that regulates blood sugar levels and appetite – grew by 8% in the first half of the year, down from 21% last year. Sales of obesity drugs including Wegovy increased by 56%, taking total sales 16% higher to 155bn Danish kroner (£18bn). Profit before tax climbed by 24% to 70.8bn kroner. The company has lost market share to its US rival Eli Lilly's Mounjaro, which studies have shown to be more effective, as well as cheaper versions made by generic drugmakers. It has also been hit by 'compounding' in the US, where pharmacies make up medications from ingredients, even though the US regulator declared an end to the practice recently. Novo Nordisk's outgoing chief executive, Lars Fruergaard Jørgensen, said that the copycat market had 'equal size to our business' and that compounded versions of Wegovy were sold at a 'much lower price point'. Its finance chief, Karsten Munk Knudsen, said the company was pursuing various strategies, including lawsuits against compounding pharmacies and expanding its US direct-to-consumer platform, NovoCare, launched in March. The company might also pursue 'cash sales' directly to patients elsewhere. Jørgensen said Novo Nordisk was taking measures to 'sharpen our commercial execution further, and ensure efficiencies in our cost base while continuing to invest in future growth'. He said it would probably not be able to avoid layoffs, but that no decision had been made. He said it would be up to Maziar Mike Doustdar, who takes over as CEO on Thursday, to make such a decision. The company is now expecting sales growth of between 8% and 14% at constant exchange rates in 2025, down sharply from its previous estimate of 13% to 21%. Novo Nordisk also disclosed that it had ditched several weight-loss drugs in development, including one that has just completed an intermediate (phase II) clinical study, 'due to portfolio considerations'. The company faces a class action lawsuit in the US from investors, who claim that it misled them with optimistic growth forecasts in the lucrative weight loss market. The UBS analyst Matthew Weston said: 'We expect GLP-1 compounders to remain in the US, which limits cash-pay uptake and leaves an uncertain outlook for US Wegovy. Sign up to Business Today Get set for the working day – we'll point you to all the business news and analysis you need every morning after newsletter promotion 'President Trump's proposal to reimburse GLP-1 obesity in Medicare could add significant volume uplift, but most-favoured-nation demands to offer US cash sales at European prices could significantly reduce value.' Derren Nathan, the head of equity research at Hargreaves Lansdown, said: 'Tariffs and drug pricing policy are another threat Mike Doustdar will need to tackle head-on if one of Denmark's greatest success stories is to regain its crown as Europe's most valuable company. 'The 15% blanket rate on EU imports is not necessarily the end of the story as Donald Trump dangles the prospect of levies of up to 250% on pharmaceutical imports under a separate section 232 investigation.'
The Independent
an hour ago
- The Independent
One in five NHS doctors considering leaving UK profession, report warns
The Government's pledge to cut hospital waiting lists is at risk unless more is done to retain doctors in the NHS, the medical regulator has warned. Almost one in five (19%) of doctors are considering quitting being a doctor in the UK, the General Medical Council (GMC) said. And one in eight (12%) are considering leaving the UK to work abroad, according to GMC figures. The main reason given for considering a move abroad was that doctors are 'treated better' in other countries, with an increase in pay cited as the second most common reason for plans to emigrate. Overall, some 43% of doctors told the GMC that they had researched career opportunities in other countries. Some 15% of doctors reported they had taken 'hard steps' towards leaving UK practice – such as applying for roles overseas or contacting recruiters. 'We must be alive to the ongoing risks to retention of doctors and the impact of losing talented staff,' the authors of the GMC's latest report wrote. 'This could threaten Government ambitions to reduce waiting times and deliver better care to patients.' Prime Minister Sir Keir Starmer has pledged that, by July 2029, 92% of patients will be seen within 18 weeks for routine hospital treatment such as hip and knee replacements. The GMC's latest report also raised concerns about career progression for medics. The report highlighted that 8% of doctors who felt they could progress their career said they were likely to leave the UK medical profession and had taken hard steps towards doing so, compared with 27% of those who did not feel this way. Overall one in three doctors said they are unable to progress their education, training and careers in the way they want, according to the report, which is based on responses from 4,697 doctors around the UK. It found that those who did not feel as though their careers were progressing the way they would wish were at higher risk of burnout and were less satisfied with their work. The GMC said that workloads, competition for posts, and lack of senior support for development are adversely impacting career hopes for UK doctors. Charlie Massey, chief executive of the GMC, said: 'Like any profession, doctors who are disillusioned with their careers will start looking elsewhere. 'Doctors need to be satisfied, supported, and see a hopeful future for themselves, or we may risk losing their talent and expertise altogether. 'Achieving this requires modernising the current training system, so it meets the needs of doctors and patients.' It comes as Health Secretary Wes Streeting and the British Medical Association are locked in talks to avert further strike action by resident doctors after a five-day walkout in July. Resident doctors, formerly known as junior doctors, are in a dispute with the Government over pay and a lack of places for doctors in training. Commenting on the GMC report, Billy Palmer, senior fellow at the Nuffield Trust think tank, said: 'Pay and industrial action have been a lightning rod for dissatisfaction among doctors but this survey puts a spotlight on the wider difficulties facing the medical profession. 'Job guarantees, better rotas and placements, and protection of training time all need to be on the table. 'Addressing the burden of medical graduates' student debt by gradually writing off loans could also be a promising way to reward doctors' NHS service. With fewer than three in five doctors in 'core training' remaining in the NHS eight years later, unless warnings from this survey are dealt with, we'll continue to lose these skilled clinicians.' A Department of Health and Social Care spokesperson said: 'The findings in this report are further evidence of what we know, that after more than a decade of neglect, doctors have legitimate complaints about their conditions, including issues with training bottlenecks and career progression. 'We want to work with them to address these and improve their working lives, which includes our plans set out in the 10 Year Health Plan to prioritise UK graduates and increase speciality training posts. 'This Government is committed to improving career opportunities and working conditions, bringing in ways to recognise and reward talent – as well as freeing up clinicians' time by cutting red tape.'
The Independent
an hour ago
- The Independent
Warning of NHS staffing crisis as fifth of doctors tempted to move abroad
Sir Keir Starmer's pledge to cut hospital waiting lists is at risk unless more is done to retain doctors, as one in five consider leaving the UK to work abroad, the medical regulator has warned. The General Medical Council (GMC) said 19 per cent of doctors are considering the move – with claims doctors are 'treated better' in other countries given as the main reason. Better pay was the second most common reason for plans to emigrate. The news comes as the government faces ongoing strike action from resident doctors over its refusal to give in to their demands for a 29 per cent salary increase. According to the GMC, 43 per cent of doctors surveyed said they had researched career opportunities in other countries, and 15 per cent had taken 'hard steps' towards working outside the UK – such as applying for roles overseas or contacting recruiters. Sir Keir has pledged that 92 per cent of patients will be seen within 18 weeks for routine hospital treatment such as hip and knee replacements by July 2029 – a vow the GMC said could now be under threat. 'We must be alive to the ongoing risks to retention of doctors and the impact of losing talented staff,' the authors of the GMC's latest report warned. 'This could threaten government ambitions to reduce waiting times and deliver better care to patients.' The newly agreed salary for doctors on foundation training in England is between £38,831 and £44,439, with specialist training salaries rising to £73,992. That includes the 5.4 per cent increase awarded earlier this year, but does not include London weighting. The average salary for a general practitioner is £84,000, according to NHS data, while specialists such as radiotherapists can earn up to £350,000. By comparison, resident doctors in the US are paid on average between £51,000 and £86,000, according to Glassdoor, but some surgeons can earn upwards of £500,000 a year. Average salaries for doctors in Canada sit around £122,000, with peak pay at £236,000. In Australia, recruitment agency Medrecruit said resident medical officers, who are the equivalent of foundation year two doctors in the UK, earn between £31,748 to £46,402, while more senior doctors can earn between £58,400 and £77,800. The GMC's latest report, based on responses from 4,697 doctors, also raised concerns about career progression for medics in the UK. Overall, one in three doctors said they are unable to progress their education, training and careers in the way they want. It found that those who felt this way were at higher risk of burnout and were less satisfied with their work, while 8 per cent of doctors who felt they could not progress their career in the UK were likely to look for work overseas. The BMA has already raised concerns with ministers over the number of resident doctors unable to get specialist training jobs, with 30,000 doctors applying for around 10,000 posts each year. Charlie Massey, chief executive of the GMC, said: 'Like any profession, doctors who are disillusioned with their careers will start looking elsewhere. Doctors need to be satisfied, supported, and see a hopeful future for themselves, or we may risk losing their talent and expertise altogether. 'Achieving this requires modernising the current training system, so it meets the needs of doctors and patients.' It comes as Health Secretary Wes Streeting and the BMA remain locked in talks to avert further strike action. Following a meeting on Wednesday, BMA resident doctors' committee co-chairs, Dr Ross Nieuwoudt and Dr Melissa Ryan said 'we feel that we have achieved a greater mutual understanding than in previous talks' and they had agreed on a window for further negotiations this month. Commenting on the GMC report, Billy Palmer, senior fellow at the Nuffield Trust think tank, said the survey shone a spotlight on the wider difficulties facing the medical profession. 'Job guarantees, better rotas and placements, and protection of training time all need to be on the table. 'Addressing the burden of medical graduates' student debt by gradually writing off loans could also be a promising way to reward doctors' NHS service. With fewer than three in five doctors in 'core training' remaining in the NHS eight years later, unless warnings from this survey are dealt with, we'll continue to lose these skilled clinicians.'
